Key Points The Danish pharmaceutical giant makes the blockbuser drug Wegovy. It was the first GLP-1 medication approved by the FDA, back in 2021. 10 stocks we like better than Novo Nordisk › Novo Nordisk's (NYSE: NVO) leading medications have been hot discussion topics for years. Many Americans might not recognize the Danish pharmaceutical company's name, but by now they've at least heard tell of its leading products: Wegovy, approved to treat obesity, and its sibling Ozempic, indicated for diabetes ...